Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Integrity Clinical Research Center, Inc.
EIR
•Integrity Clinical Research Center, Inc.•April 18, 2024

Integrity Clinical Research Center, Inc. – FDA EIR, Apr 18, 2024

Record Details

An FDA inspection of Integrity Clinical Research Center, LLC (ICRC) in Hialeah, FL, was conducted from April 15 to April 18, 2024. As a biopharmaceutical clinical facility conducting FDA-regulated research, ICRC operates under the Federal Food, Drug, and Cosmetic (FD&C) Act. This was ICRC's first FDA inspection.

The inspection involved a comprehensive review of study records, including informed consents, protocols, adverse event reporting, and clinical source data. Key observations noted during the inspection included a verbalized discussion point with management concerning Good Documentation Practice related to off-site storage of investigational product retention samples, although these specific samples were not required for the assignment. Additionally, the investigator observed that the investigational product storage refrigerator lacked an active temperature monitoring device and contained employee lunches; management attributed this to a broken lunch fridge and medication being from closed studies. The site also did not maintain a dedicated screening and enrollment log, and the absence of a sealed randomization schedule was clarified by the sponsor as being due to dynamic randomization.

Significantly, no Form FDA 483, Inspectional Observations, was issued at the conclusion of the inspection, indicating that no formal violations were documented. While no specific corrective actions were mandated, management received a general warning regarding potential administrative actions, fines, or prosecution should future violations of the FD&C Act be identified. The inspection concluded with no refusals or samples collected.

Company
Integrity Clinical Research Center, Inc.
Inspection date
April 18, 2024
Product type
drugs
Office
Center for Drug Evaluation and Research
People
  • Emily C. Caldwell (investigator)
  • Pastor Torres (company_representative)
  • Carlos Maza (other)
  • Jason Wyllie (company_representative)
  • Yaimary Diaz (company_representative)
View Company Profile

ID · c7794950-8ad7-40da-b152-3a60f6dc4d3e

Violation Codes1
21 CFR 312

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Integrity Clinical Research Center, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.